Anne Elizabeth Kellogg is a notable inventor based in Ayden, NC (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to her name, her work has the potential to impact medical research and treatment.

Latest Patents

Kellogg's latest patents include the monoclonal antibody DS6 and its associated tumor-associated antigen CA6. The present application describes a monoclonal antibody selected from the group consisting of monoclonal antibody DS6, monoclonal antibodies that specifically bind to the antigen or epitope bound by monoclonal antibody DS6, and fragments of the foregoing that specifically bind to the antigen or epitope bound by monoclonal antibody DS6. Methods of use of such antibodies and the isolated antigen bound by such antibodies are also described.

Career Highlights

Kellogg is affiliated with East Carolina University, where she conducts her research and development. Her work in the field of monoclonal antibodies has garnered attention for its innovative approach to targeting specific antigens.

Collaborations

Kellogg collaborates with Diane A Semer, who is also a prominent figure in her field. Their partnership enhances the research capabilities and fosters innovation in their projects.

Conclusion

Anne Elizabeth Kellogg's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com